Advertisement

MMW - Fortschritte der Medizin

, Volume 160, Issue 21–22, pp 46–50 | Cite as

Zystektomie — Harnableitung — Chemotherapie

Management des muskelinvasiven Harnblasenkarzinoms

  • Alexander KarlEmail author
FORTBILDUNG . SCHWERPUNKT
  • 107 Downloads

Wird ein muskelinvasiver oder ein therapieresistenter nicht-muskelinvasiver Blasentumor diagnostiziert, steht dem Patienten eine radikale Zystektomie bevor. Um sich für eine in der Folge notwendige Form der Harnableitung entscheiden zu können, muss der Patient im Vorfeld ausführlich über die jeweiligen Vor- und Nachteile aufgeklärt werden.

Management of muscle invasive cancer of the urinary bladder

Keywords

Bladder cancer neoadjuvant and adjuvant therapy radical cystectomy enhanced recovery after surgery ERAS 

Literatur

  1. 1.
    Ahmadi H, Lee CT (2015) Health-related quality of life with urinary diversion. Curr Opin Urol 25:562–569CrossRefGoogle Scholar
  2. 2.
    Ali AS, Hayes MC, Birch B et al (2015) Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol 41:295–299CrossRefGoogle Scholar
  3. 3.
    Aziz A, May M, Burger M et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156–163CrossRefGoogle Scholar
  4. 4.
    Bochner BH, Sjoberg DD, Laudone VP et al (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390CrossRefGoogle Scholar
  5. 5.
    Buchner A, Grimm T, Schneevoigt BS et al (2017) Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage. Scand J Urol 51:130–136CrossRefGoogle Scholar
  6. 6.
    Cody JD, Nabi G, Dublin N et al (2012) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. https://doi-org.emedien.ub.uni-muenchen.de/10.1002/14651858.CD003306.pub2Google Scholar
  7. 7.
    Geschwend JE, Heck MM, Lehmann J et al (2016) Limited versus extended pelvic lymphadenectomyin patients with bladder cancer undergoing radical cystectomy: survival results from randomized trail (LEA AUO AB 25/02, NCTO1215071). JCO 34(suppl):abstr 4503Google Scholar
  8. 8.
    Gierth M, Mayr R, Aziz A et al (2015) Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol 141:1819–1826CrossRefGoogle Scholar
  9. 9.
    Goossens-Laan CA, Leliveld AM, Verhoeven RH et al (2014) Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. Int J Cancer 135:905–912CrossRefGoogle Scholar
  10. 10.
    Gschwend J, Retz M, Kuebler H (2010) Indications and oncological outcome of radical cystectomy for urothelial bladder cancer. Eur Urol 9:10–18CrossRefGoogle Scholar
  11. 11.
    Karl A, Rittler P, Buchner A et al (2009) Prospective assessment of malnutrition in urologic patients. Urology 73:1072–1076CrossRefGoogle Scholar
  12. 12.
    Karl A, Buchner A, Becker A et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191:335–340CrossRefGoogle Scholar
  13. 13.
    Pang KH, Groves R, Venugopal S et al (2017) Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol pii:S0302-2838(17)30660-7. https://doi-org.emedien.ub.uni-muenchen.de/10.1016/j.eururo.2017.07.031Google Scholar
  14. 14.
    Roghmann F, Ravi P, Hanske J et al (2015) Perioperative outcomes after radical cystectomy at NCI-designated centres: are they any better? Can Urol Assoc J 9:207–212CrossRefGoogle Scholar
  15. 15.
    Tyritzis SI, Wiklund NP (2018) Is the open cystectomy era over? An update on the available evidence. Int J Urol 25(3):187. https://doi-org.emedien.ub.uni-muenchen.de/10.1111/iju.13497Google Scholar
  16. 16.
    Udovicich C, Perera M, Huq M et al (2017) Hospital volume and perioperative outcomes for radical cystectomy: a population study. BJU Int 119(Suppl 5):26–32CrossRefGoogle Scholar
  17. 17.
    Witjes AJ, Lebret T, Comperat EM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71:462–475CrossRefGoogle Scholar
  18. 18.
    Xia L, Guzzo TJ (2017) Preoperative anemia and low hemoglobin level are associated with worse clinical outcomes in patients with bladder cancer undergoing radical cystectomy: a Meta-analysis. Clin Genitourin Cancer 15:263–272.e4CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für UrologieBarmherzige Brüder MünchenMünchenDeutschland

Personalised recommendations